Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec 6;15(12):e0009974.
doi: 10.1371/journal.pntd.0009974. eCollection 2021 Dec.

Left ventricular systolic dysfunction predicted by artificial intelligence using the electrocardiogram in Chagas disease patients-The SaMi-Trop cohort

Bruno Oliveira de Figueiredo Brito  1 , Zachi I Attia  2 , Larissa Natany A Martins  3   4 , Pablo Perel  5 , Maria Carmo P Nunes  1 , Ester Cerdeira Sabino  6 , Clareci Silva Cardoso  7 , Ariela Mota Ferreira  8 , Paulo R Gomes  1   3 , Antonio Luiz Pinho Ribeiro  1   3 , Francisco Lopez-Jimenez  2
Affiliations

Left ventricular systolic dysfunction predicted by artificial intelligence using the electrocardiogram in Chagas disease patients-The SaMi-Trop cohort

Bruno Oliveira de Figueiredo Brito et al. PLoS Negl Trop Dis. .

Erratum in

Abstract

Background: Left ventricular systolic dysfunction (LVSD) in Chagas disease (ChD) is relatively common and its treatment using low-cost drugs can improve symptoms and reduce mortality. Recently, an artificial intelligence (AI)-enabled ECG algorithm showed excellent accuracy to detect LVSD in a general population, but its accuracy in ChD has not been tested.

Objective: To analyze the ability of AI to recognize LVSD in patients with ChD, defined as a left ventricular ejection fraction determined by the Echocardiogram ≤ 40%.

Methodology/principal findings: This is a cross-sectional study of ECG obtained from a large cohort of patients with ChD named São Paulo-Minas Gerais Tropical Medicine Research Center (SaMi-Trop) Study. The digital ECGs of the participants were submitted to the analysis of the trained machine to detect LVSD. The diagnostic performance of the AI-enabled ECG to detect LVSD was tested using an echocardiogram as the gold standard to detect LVSD, defined as an ejection fraction <40%. The model was enriched with NT-proBNP plasma levels, male sex, and QRS ≥ 120ms. Among the 1,304 participants of this study, 67% were women, median age of 60; there were 93 (7.1%) individuals with LVSD. Most patients had major ECG abnormalities (59.5%). The AI algorithm identified LVSD among ChD patients with an odds ratio of 63.3 (95% CI 32.3-128.9), a sensitivity of 73%, a specificity of 83%, an overall accuracy of 83%, and a negative predictive value of 97%; the AUC was 0.839. The model adjusted for the male sex and QRS ≥ 120ms improved the AUC to 0.859. The model adjusted for the male sex and elevated NT-proBNP had a higher accuracy of 0.89 and an AUC of 0.874.

Conclusion: The AI analysis of the ECG of Chagas disease patients can be transformed into a powerful tool for the recognition of LVSD.

PubMed Disclaimer

Conflict of interest statement

I have read the journal’s policy and some authors of this manuscript have the following competing interests: Mayo Clinic has licensed the underlying technology to EKO, a maker of digital stethoscopes with embedded ECG electrodes. Mayo Clinic may receive financial benefit from the use of this technology, but at no point will Mayo Clinic benefit financially from its use for the care of patients at Mayo Clinic. F.L.J. and Z.I.A. may also receive financial benefit from this agreement. There is a patent filing covering some of the technology described in this manuscript (USPO application WO2019070978A1).

Figures

Fig 1
Fig 1. Flow chart describing study design.
Fig 2
Fig 2. Receiver Operating Characteristic (ROC) curves for AI prediction of LVSD (n = 1,304).
A: All patients (n = 1,304), univariate analysis; B: All patients (n = 1,304), adjusted for the male sex and QRS ≥ 120ms; C: All patients (n = 1,304), adjusted for the male sex and NT-proBNP; D: Only the patients with major ECG abnormalities (n = 776), adjusted for the male sex and NT-proBNP.
Fig 3
Fig 3. Electrocardiogram of a patient with LVSD recognized by the AI algorithm.
See this image and copyright information in PMC

References

    1. Nunes MC, Dones W, Morillo CA, Encina JJ, Ribeiro AL. Chagas disease: an overview of clinical and epidemiological aspects. Journal of the American College of Cardiology. 2013;62(9):767–76. Epub 2013/06/19. doi: 10.1016/j.jacc.2013.05.046 - DOI - PubMed
    1. Ribeiro AL, Nunes MP, Teixeira MM, Rocha MO. Diagnosis and management of Chagas disease and cardiomyopathy. Nature reviews Cardiology. 2012;9(10):576–89. Epub 2012/08/01. doi: 10.1038/nrcardio.2012.109 - DOI - PubMed
    1. Chagas C, Villela E. Cardiac form of American Trypanosomiasis. Memorias do Instituto Oswaldo Cruz. 1922;14(1):5–61.
    1. Ribeiro AL, Marcolino MS, Prineas RJ, Lima-Costa MF. Electrocardiographic abnormalities in elderly Chagas disease patients: 10-year follow-up of the Bambui Cohort Study of Aging. Journal of the American Heart Association. 2014;3(1):e000632. Epub 2014/02/11. doi: 10.1161/JAHA.113.000632 - DOI - PMC - PubMed
    1. Nascimento BR, Araujo CG, Rocha MO, Domingues JD, Rodrigues AB, Barros MV, et al.. The prognostic significance of electrocardiographic changes in Chagas disease. Journal of electrocardiology. 2012;45(1):43–8. Epub 2011/06/28. doi: 10.1016/j.jelectrocard.2011.04.011 - DOI - PubMed